First pain drug in new class comes from snail
Elan Pharmaceuticals received Food & Drug Administration approval in late December for Prialt (ziconotide intrathecal infusion), a new alternative for patients with severe chronic pain.The drug is the first in a new class of non-opioid pain relievers known as N-type calcium-channel blockers and is the synthetic equivalent of a naturally occurring conopeptide found in the venom of a South Pacific marine snail, Conus magus.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Related Content
